Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masashi Asai

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Rinsho Shinkeigaku = Clinical Neurology|December 1, 2012
[A pathogenic mechanism of N-terminally pyroglutamylated Aβ and possible application of Alzheimer's disease by inhibition of the pyroglutamylation]Nobuhisa Iwata, Masashi Asai
Journal of Biochemistry|March 25, 2017
Paradigm shift from diagnosing patients based on common symptoms to categorizing patients into subtypes with different pathogenic mechanisms to guide treatment for Alzheimer's diseaseKeiro Shirotani, Masashi Asai, Nobuhisa Iwata
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 5, 2017
Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome PatientsMasashi Asai, Takashi Kawakubo, Ryotaro Mori, et al.
Zoological Science|February 2, 2022
A New Species of Acoela Possessing a Middorsal Appendage with a Possible Sensory FunctionMasashi Asai, Hideyuki Miyazawa, Ryuji Yanase, et al.
Biological & Pharmaceutical Bulletin|March 3, 2017
Neprilysin Is Suppressed by Dual-Specificity Tyrosine-Phosphorylation Regulated Kinase 1A (DYRK1A) in Down-Syndrome-Derived FibroblastsTakashi Kawakubo, Ryotaro Mori, Keiro Shirotani, et al.
Gene|December 20, 2021
Molecular profiling of ginsenoside metabolites to identify estrogen receptor alpha activityMami Kikegawa, Azusa Nakajima, Jing Yu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 13, 2011
An alternative metabolic pathway of amyloid precursor protein C-terminal fragments via cathepsin B in a human neuroglioma modelMasashi Asai, Sosuke Yagishita, Nobuhisa Iwata, et al.
Biochemical and Biophysical Research Communications|November 28, 2006
Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease Abeta secretionMasashi Asai, Nobuhisa Iwata, Ayumu Yoshikawa, et al.
Molecular Medicine Reports|April 5, 2024
Induction of the human <i>CDC45</i> gene promoter activity by natural compound <i>trans</i>‑resveratrolJun Arakawa, Hikaru Kondoh, Tokiyoshi Matsushita, et al.
Journal of Neuroscience Research|October 5, 2010
Efficient four-drug cocktail therapy targeting amyloid-β peptide for Alzheimer's diseaseMasashi Asai, Nobuhisa Iwata, Taisuke Tomita, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Rinsho Shinkeigaku = Clinical Neurology|December 1, 2012
[A pathogenic mechanism of N-terminally pyroglutamylated Aβ and possible application of Alzheimer's disease by inhibition of the pyroglutamylation]Nobuhisa Iwata, Masashi Asai
Journal of Biochemistry|March 25, 2017
Paradigm shift from diagnosing patients based on common symptoms to categorizing patients into subtypes with different pathogenic mechanisms to guide treatment for Alzheimer's diseaseKeiro Shirotani, Masashi Asai, Nobuhisa Iwata
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 5, 2017
Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome PatientsMasashi Asai, Takashi Kawakubo, Ryotaro Mori, et al.
Zoological Science|February 2, 2022
A New Species of Acoela Possessing a Middorsal Appendage with a Possible Sensory FunctionMasashi Asai, Hideyuki Miyazawa, Ryuji Yanase, et al.
Biological & Pharmaceutical Bulletin|March 3, 2017
Neprilysin Is Suppressed by Dual-Specificity Tyrosine-Phosphorylation Regulated Kinase 1A (DYRK1A) in Down-Syndrome-Derived FibroblastsTakashi Kawakubo, Ryotaro Mori, Keiro Shirotani, et al.
Gene|December 20, 2021
Molecular profiling of ginsenoside metabolites to identify estrogen receptor alpha activityMami Kikegawa, Azusa Nakajima, Jing Yu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 13, 2011
An alternative metabolic pathway of amyloid precursor protein C-terminal fragments via cathepsin B in a human neuroglioma modelMasashi Asai, Sosuke Yagishita, Nobuhisa Iwata, et al.
Biochemical and Biophysical Research Communications|November 28, 2006
Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease Abeta secretionMasashi Asai, Nobuhisa Iwata, Ayumu Yoshikawa, et al.
Molecular Medicine Reports|April 5, 2024
Induction of the human <i>CDC45</i> gene promoter activity by natural compound <i>trans</i>‑resveratrolJun Arakawa, Hikaru Kondoh, Tokiyoshi Matsushita, et al.
Journal of Neuroscience Research|October 5, 2010
Efficient four-drug cocktail therapy targeting amyloid-β peptide for Alzheimer's diseaseMasashi Asai, Nobuhisa Iwata, Taisuke Tomita, et al.
Pageof 3